JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tomita, M.
Right arrow Articles by Awazu, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tomita, M.
Right arrow Articles by Awazu, S.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CALCIUM COMPOUNDS
*CALCIUM, ELEMENTAL
*CAPRIC ACID

Absorption-enhancing mechanism of sodium caprate and decanoylcarnitine in Caco-2 cells

M Tomita, M Hayashi and S Awazu

Department of Biopharmaceutics, Tokyo College of Pharmacy, Japan.

The mechanism of action of the absorption enhancers such as sodium caprate (C10) and decanoylcarnitine (DC) was examined. Both C10 and DC increased the epithelial permeability of fluorescein isothiocyanate dextran 4000 and decreased the transepithelial electrical resistance in Caco-2 cell monolayer. Irrespective of the presence or absence of mucosal calcium, C10 rapidly increased intracellular calcium levels dose-dependently. Compound 48/80, a phospholipase C inhibitor, prevented the increases of the intracellular calcium level and permeability of fluorescein isothiocyanate dextran 4000 by C10. Furthermore, N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide hydrochloride, a strong calmodulin inhibitor, also significantly decreased the enhancing effect of C10. These results suggest that C10 releases calcium from intracellular stores via activation of phospholipase C in plasma membrane. The increase of the calcium levels was considered to induce the contraction of calmodulin-dependent actin microfilament, followed by dilatation of the paracellular route. Although DC also increased intracellular calcium levels, neither compound 48/80 nor N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide hydrochloride decreased the enhancing effect of DC. The enhancing mechanisms were different for C10 and DC.

Volume 272, Issue 2, pp. 739-743, 02/01/1995
Copyright © 1995 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
C. B. Coyne, C. M. P. Ribeiro, R. C. Boucher, and L. G. Johnson
Acute Mechanism of Medium Chain Fatty Acid-Induced Enhancement of Airway Epithelial Permeability
J. Pharmacol. Exp. Ther., May 1, 2003; 305(2): 440 - 450.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
J D Soderholm, G Olaison, K H Peterson, L E Franzen, T Lindmark, M Wiren, C Tagesson, and R Sjodahl
Augmented increase in tight junction permeability by luminal stimuli in the non-inflamed ileum of Crohn's disease
Gut, March 1, 2002; 50(3): 307 - 313.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
C. J. Watson, M. Rowland, and G. Warhurst
Functional modeling of tight junctions in intestinal cell monolayers using polyethylene glycol oligomers
Am J Physiol Cell Physiol, August 1, 2001; 281(2): C388 - C397.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
T. Lindmark, Y. Kimura, and P. Artursson
Absorption Enhancement through Intracellular Regulation of Tight Junction Permeability by Medium Chain Fatty Acids in Caco-2 Cells
J. Pharmacol. Exp. Ther., January 1, 1998; 284(1): 362 - 369.
[Abstract] [Full Text]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1995 by the American Society for Pharmacology and Experimental Therapeutics.